Back
AnaptysBio Vs. Agios Pharmaceuticals Industry Stock Comparison
Buy
60
ANAB
AnaptysBio
Last Price:
34.83
Seasonality Move:
26.98%
Sell
31
AGIO
Agios Pharmaceuticals
Last Price:
46.60
Seasonality Move:
1.31%
Buy
60
AnaptysBio (ANAB)
is a Buy
Is AnaptysBio a Buy, Sell or Hold?
- The current AnaptysBio [ANAB] share price is $35.57. The Score for ANAB is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- ANAB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
31
Agios Pharmaceuticals (AGIO)
is a Sell
Is Agios Pharmaceuticals a Buy, Sell or Hold?
- The current Agios Pharmaceuticals [AGIO] share price is $45.76. The Score for AGIO is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- AGIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ANAB Stock Price Chart
What is AnaptysBio's stock price today?
-
The AnaptysBio share price today is $35.57
The current trend is moderately bearish and ANAB is experiencing slight selling pressure.
AGIO Stock Price Chart
What is Agios Pharmaceuticals's stock price today?
-
The Agios Pharmaceuticals share price today is $45.76
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AGIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
ANAB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.66 | Buy |
| Relative Strength Index (14 RSI): | 47.21 | Sell |
| Chaikin Money Flow: | -223759 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
AGIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.28 | Buy |
| Relative Strength Index (14 RSI): | 51.57 | Buy |
| Chaikin Money Flow: | -273966 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
ANAB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.88 | Sell |
| 20-day SMA: | 37.04 | Sell |
| 50-day SMA: | 35.68 | Sell |
| 200-day SMA: | 26.29 | Buy |
| 8-day EMA: | 37.19 | Sell |
| 20-day EMA: | 36.83 | Sell |
| 50-day EMA: | 34.71 | Buy |
| 200-day EMA: | 27.86 | Buy |
AGIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.01 | Sell |
| 20-day SMA: | 45.43 | Buy |
| 50-day SMA: | 45.71 | Buy |
| 200-day SMA: | 34.85 | Buy |
| 8-day EMA: | 45.92 | Sell |
| 20-day EMA: | 45.55 | Buy |
| 50-day EMA: | 44.82 | Buy |
| 200-day EMA: | 37.46 | Buy |
AnaptysBio Earnings Growth & ANAB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.20 per share, a decrease next quarter of $0.18 per share, a decrease this year of $0.65 per share, and a decrease next year of $0.06 per share.
Agios Pharmaceuticals Earnings Growth & AGIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $7.10 per share, a decrease next quarter of $7.23 per share, an increase this year of $7.55 per share, and a decrease next year of $7.17 per share.
AnaptysBio Technical Analysis
| Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Agios Pharmaceuticals Technical Analysis
| Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||